Figure 4From: Potential serum biomarkers for glioblastoma diagnostic assessed by proteomic approachesReproducibility of SELDI ToF mass spectra. Different relative intensities of peaks in glioblastoma diagnosed (n = 35) vs control group (30); (A) peaks at m/z 9192.84 were up-regulated in glioblastoma patients. (B) peaks at m/z 10836.09, 13153.66 were up-regulated in glioblastoma patients. (C) peaks at m/z 23466.27 were up-regulated in glioblastoma patients.Back to article page